Boiron SA (France) Today
| BOI Stock | EUR 25.00 0.55 2.25% |
PerformanceVery Weak
| Odds Of DistressLow
|
Boiron SA is trading at 25.00 as of the 26th of February 2025, a 2.25% up since the beginning of the trading day. The stock's open price was 24.45. Boiron SA has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 27th of January 2025 and ending today, the 26th of February 2025. Click here to learn more.
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. Boiron SA was founded in 1932 and is headquartered in Messimy, France. BOIRON operates under Drug Manufacturers - Major classification in France and is traded on Paris Stock Exchange. The company has 17.37 M outstanding shares. More on Boiron SA
Moving against Boiron Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Boiron Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Boiron SA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Boiron SA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Thematic Idea | Iron (View all Themes) |
| Business Concentration | Iron, Drug Manufacturers - Major, Healthcare (View all Sectors) |
Boiron SA (BOI) is traded on Euronext Paris in France and employs 2,794 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 730.22 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Boiron SA's market, we take the total number of its shares issued and multiply it by Boiron SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Boiron SA operates under Healthcare sector and is part of Drug Manufacturers - Major industry. The entity has 17.37 M outstanding shares.
Boiron SA has accumulated about 217.25 M in cash with 33.32 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.4.
Check Boiron SA Probability Of Bankruptcy
Ownership AllocationBoiron SA holds a total of 17.37 Million outstanding shares. Boiron SA shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 75.48 percent of Boiron SA outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Boiron Ownership Details
Boiron SA Risk Profiles
Although Boiron SA's alpha and beta are two of the key measurements used to evaluate Boiron SA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.55 | |||
| Standard Deviation | 2.19 | |||
| Variance | 4.78 | |||
| Risk Adjusted Performance | (0.07) |
Boiron Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Boiron SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Boiron SA Corporate Management
Elected by the shareholders, the Boiron SA's board of directors comprises two types of representatives: Boiron SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Boiron. The board's role is to monitor Boiron SA's management team and ensure that shareholders' interests are well served. Boiron SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Boiron SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Valrie LorentzPoinsot | GM Director | Profile | |
| Fabrice Rey | Group Treasurer | Profile | |
| Eric Lambert | S Gen | Profile | |
| Christine Place | Deputy Mang | Profile | |
| Patrice Varraut | Director Operations | Profile | |
| JeanChristophe Bayssat | Chief GM | Profile |
Other Information on Investing in Boiron Stock
Boiron SA financial ratios help investors to determine whether Boiron Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boiron with respect to the benefits of owning Boiron SA security.